January 6th, 2007
Long-acting Octreotide, Not Beneficial to Liver Cancer Patients
According to the results of a new double blind study published in the January 2007 issue of Hepatology (the official journal of the American Association for the Study of Liver Diseases (AASLD)), long-acting octreotide does not improve outcomes for patients with liver cancer as compared to placebo.
Also known as hepatocellular carcinoma (HCC), liver cancer is […]
Recent Comments